| Leukocare–Petrichor Healthcare: credit, 202106– convertible loan totalling $15m incl Petrichor HCM |
2021-06-23 |
| Leukocare–Petrichor Healthcare: investment, 202106 equity investment $2.5m from Petrichor HCM |
2021-06-23 |
| Leukocare–SEVERAL: credit, 202106– convertible loan $15m led by Petrichor HCM + incl existing shareholders |
2021-06-23 |
| 908 Devices–Sartorius: bioprocess control technology, 202106 collab product integration Rebel media analyzer with SIMCA data exploratory tool |
2021-06-22 |
| Merck (DE)–Insilico Medicine: AI-based drug discovery s/w, 202106 supply existent Merck KGaA deploys Chemistry42 molecule design software |
2021-06-22 |
| Sirion Biotech–PerkinElmer: investment, 202106– acquisition by PerkinElmer ANNOUNCED |
2021-06-22 |
| Ochre Bio–Apollo Health Ventures: investment, 202106 seed financing round totalling $9.6m incl co-investor Apollo HV |
2021-06-16 |
| Alentis Therapeutics–High-Tech Gründerfonds: investment, 202106 financing round Series B totalling CHF60m incl existing + co-investor HTGF |
2021-06-15 |
| Quadira Biosciences–Veraxa Biotech: antibody-drug conjugates, 202106– collab developm €na using 3D CoSeedis platform + microfluidics technology |
2021-06-14 |
| ITM–FRIBA Investment: investment, 202106 financing round totalling €25m incl new investor FRIBA Investment |
2021-06-10 |
| ITM–Portland Holdings: investment, 202106 financing round totalling €25m incl investor Portland Holdings |
2021-06-10 |
| ITM–SEVERAL: investment, 202106 financing round €25m private equity incl Portland Holdings + FRIBA Investment |
2021-06-10 |
| Boehringer–Lifebit: Lifebit REAL platform, 202106– collab long-term using NLP + AI for detection + early reporting of infectious disease outbreaks |
2021-06-08 |
| Avi Medical–SEVERAL: investment, 202106 financing round Series A €28.5m led by Heal Capital + Addition |
2021-06-07 |
| Innovative Molecules–Akampion: public relations, 202106 service existent by Akampion |
2021-06-07 |
| Innovative Molecules–Life Sciences Partners: investment, 202106 financing round Series A totalling €20m incl lead investor LSP |
2021-06-07 |
| Innovative Molecules–SEVERAL: investment, 202106 financing round Series A €20m led by LSP |
2021-06-07 |
| Corat Therapeutics–Germany (govt): grant, 202106– up to €7m grant from BMBF from Covid-19 drug programme |
2021-06-03 |
| Corat Therapeutics–Lower Saxony (govt): investment, 202106 3rd financing round totalling €5.7m? incl existing investor NBank Capital |
2021-06-03 |
| Corat Therapeutics–OTHER: investment, 202106 3rd financing round totalling €5.7m? incl private investors from Braunschweig |
2021-06-03 |
| Corat Therapeutics–SEVERAL: investment, 202106 3rd financing round €5.7m? from NBank Capital + private investors |
2021-06-03 |
| AstraZeneca–Celonis: management execution software, 202106 supply existent customer AstraZeneca |
2021-06-02 |
| AstraZeneca–Proteros: small-molecule cancer drugs, 202106– collab RnD + license agreem with research funding + $62m milestones + royalties |
2021-06-02 |
| Celonis–Arena Holdings: investment, 202106 financing round Series D totalling $1b incl existing + co-investor Arena Holdings |
2021-06-02 |
| Celonis–Durable Capital: investment, 202106 financing round Series D totalling $1b incl new + co-lead investor Durable Capital Partners LP |
2021-06-02 |
| Celonis–Franklin Templeton: investment, 202106 financing round Series D totalling $1b incl new + co-investor Franklin Templeton |
2021-06-02 |
| Celonis–SEVERAL: investment, 202106 financing round Series D $1b co-led by Durable Capital Partners + T Rowe Price |
2021-06-02 |
| Celonis–Splunk Ventures: investment, 202106 financing round Series D totalling $1b incl new + co-investor Splunk Ventures |
2021-06-02 |
| Celonis–T Rowe Price: investment, 202106 financing round Series D totalling $1b incl new + co-lead investor funds+accounts managed by T Rowe Price |
2021-06-02 |
| Constellation–MorphoSys: investment, 202106–202107 acquisition cash tender offer $1.7b at $34/share by MorphoSys |
2021-06-02 |
| Danaher–Celonis: management execution software, 202106 supply existent customer Danaher Corp |
2021-06-02 |
| GoSilico–Danaher: investment, 202106 acquisition of GoSilico GmbH by Cytiva |
2021-06-02 |
| GSK–Celonis: management execution software, 202106 supply existent customer GSK |
2021-06-02 |
| L’Oréal–Celonis: management execution software, 202106 supply existent customer L’Oréal |
2021-06-02 |
| MorphoSys–Goldman Sachs: financial services, 202106 supply service GS Bank Europe SA is financial advisor with regard to acquisition of Constellation |
2021-06-02 |
| MorphoSys–Royalty Pharma: credit, 202106– up to $350m development funding bonds over 1-year period |
2021-06-02 |
| MorphoSys–Royalty Pharma: investment, 202106–202107 capital increase $100m excl subscription rights resulting in 3.9% shareholding for Royalty Pharma |
2021-06-02 |
| MorphoSys–Skadden Arps: legal services, 202106 supply service Skadden Arps Slate Meagher & Flom is legal advisor for acquisition of Constellation |
2021-06-02 |
| Pfizer–Celonis: management execution software, 202106 supply existent customer Pfizer |
2021-06-02 |
| Royalty Pharma–MorphoSys: guselkumab + otilimab et al, 202106– acquisition royalty/milestone rights $1.425b upfront + $150m milestones by Royalty |
2021-06-02 |
| Siemens–Celonis: management execution software, 202106 supply existent customer Siemens |
2021-06-02 |
| Inovedis–High-Tech Gründerfonds: investment, 202106 seed financing round totalling €1.8m incl lead investor HTGF |
2021-06-01 |
| Inovedis–SEVERAL: investment, 202106 seed financing round €1.8m led by HTGF |
2021-06-01 |
| Araxa Biosciences–Velabs Therapeutics: investment, 202105 acquisition of Araxa by Velabs company renamed Veraxa Biotech GmbH |
2021-05-31 |
| Ada Health–Bayer: investment, 202105 financing round Series B totalling $90m incl lead investor Leaps by Bayer |
2021-05-27 |
| Ada Health–F4: investment, 202105 financing round Series B totalling $90m incl co-investor F4 |
2021-05-27 |
| Ada Health–Inteligo Bank: investment, 202105 financing round Series B totalling $90m incl co-investor Inteligo Bank |
2021-05-27 |
| Ada Health–Mutschler Ventures: investment, 202105 financing round Series B totalling $90m incl co-investor Mutschler Ventures |
2021-05-27 |
| Ada Health–Samsung: investment, 202105 financing round Series B totalling $90m incl co-investor Samsung Catalyst Fund |
2021-05-27 |
| Ada Health–SEVERAL: investment, 202105 financing round Series B $90m led by Leaps by Bayer |
2021-05-27 |
| Ada Health–Vitruvian Partners: investment, 202105 financing round Series B totalling $90m incl co-investor Vitruvian Partners |
2021-05-27 |
| BrainRepair–PERSON: investment, 202105 investment Metin Colpan acquires 5% of shares of BrainRepair worth €15m |
2021-05-27 |
| Origin.bio–Acequia Capital: investment, 202105 financing round totalling $15m incl new + co-investor Acequia Capital |
2021-05-26 |
| Origin.bio–BY Capital: investment, 202105 financing round totalling $15m incl existing + co-investor BlueYard Capital |
2021-05-26 |
| Origin.bio–EQT: investment, 202105 financing round totalling $15m incl lead investor EQT Ventures |
2021-05-26 |
| Origin.bio–Inventures: investment, 202105 financing round totalling $15m incl new + co-investor Inventures |
2021-05-26 |
| Origin.bio–PERSON: investment, 202105 financing round totalling $15m incl new + co-investor Charlie Songhurst |
2021-05-26 |
| Origin.bio–PERSON: investment, 202105 financing round totalling $15m incl new + co-investor Sten Tamkivi |
2021-05-26 |
| Origin.bio–PERSON: investment, 202105 financing round totalling $15m incl new + co-investor Taavet Hinrikus |
2021-05-26 |
| Origin.bio–SEVERAL: investment, 202105 financing round $15m led by EQT Ventures |
2021-05-26 |
| Haya Therapeutics–Apollo Health Ventures: investment, 202105 seed financing round totalling CHF18m incl co-investor Apollo HV |
2021-05-20 |
| Nanoscribe–Cellink: investment, 202105 acquisition 100% of Nanoscribe Holding for preliminary €36.9m with €24.7m cash + €12.2m in Series B shares |
2021-05-19 |
| Biocatalysts Ltd–BRAIN Biotech: investment, 202105 acquisition addit 16.7% for £3.9m bringing total to 82.2% with 2 put options excercised |
2021-05-12 |
| AMSilk–Cargill: investment, 202105 financing round Series C totalling €29m incl new + co-investor Cargill |
2021-05-11 |
| AMSilk–ER Capital Holdings: investment, 202105 financing round Series C totalling €29m incl new + co-investor ER Capital Holdings |
2021-05-11 |
| AMSilk–MIG Fonds: investment, 202105 financing round Series C totalling €29m incl existing + co-investor MIG Verwaltungs AG |
2021-05-11 |
| AMSilk–Novo Group: investment, 202105 financing round Series C totalling €29m incl new + lead investor Novo Growth |
2021-05-11 |
| AMSilk–SEVERAL: investment, 202105 financing round Series C €29m led by Novo Growth with Cargill + ER Capital Holdings + MIG AG + Athos KG |
2021-05-11 |
| AMSilk–Strüngmann Group: investment, 202105 financing round Series C totalling €29m incl existing + co-investor Athos KG |
2021-05-11 |
| ITM–Trophic Communications: public relations, 202105 service existent by Trophic Communications |
2021-05-04 |
| Labforward–Berlin (govt): investment, 202105 financing round Series B 2nd closing totalling >€3m incl existing + co-investor IBB Ventures |
2021-05-04 |
| Labforward–Fielmann Group: investment, 202105 financing round Series B 2nd closing totalling >€3m incl new + lead investor Fielmann Family Office |
2021-05-04 |
| Labforward–OTHER: investment, 202105 financing round Series B 2nd closing totalling >€3m incl existing + new business angels |
2021-05-04 |
| Labforward–SEVERAL: investment, 202105 financing round Series B 2nd closing >€3m led by Fielmann Family Office bringing total Series B to >€8.5m |
2021-05-04 |
| MoonLake–Merck (DE): investment, 202105c financing round Series A incl co-investor Merck KGaA |
2021-05-03 |
| MoonLake–Merck (DE): sonelokimab, 202105– license from Merck KGaA |
2021-05-03 |
| Aquila Biolabs–Scientific Industries: investment, 202104 acquisition of Aquila Biolabs GmbH by Scientific Bioprocessing Inc |
2021-04-30 |
| Kaia Health–3VC: investment, 202104 financing round Series C totalling $75m incl existing + co-investor 3VC |
2021-04-28 |
| Kaia Health–A Round Capital: investment, 202104 financing round Series C totalling $75m incl existing + co-investor A Round Capital |
2021-04-28 |
| Kaia Health–Balderton Capital: investment, 202104 financing round Series C totalling $75m incl existing + co-investor Balderton Capital |
2021-04-28 |
| Kaia Health–Eurazeo: investment, 202104 financing round Series C totalling $75m incl existing + co-investor Eurazeo |
2021-04-28 |
| Kaia Health–Heartcore Capital: investment, 202104 financing round Series C totalling $75m incl existing + co-investor Heartcore Capital |
2021-04-28 |
| Kaia Health–Hot Cherry PR: public relations, 202104 service existent by Hot Cherry PR |
2021-04-28 |
| Kaia Health–OTHER: investment, 202104 financing round Series C totalling $75m incl undisclosed growth equity fund as lead investor |
2021-04-28 |
| Kaia Health–SEVERAL: investment, 202104 financing round Series C $75m led by undisclosed growth equity fund |
2021-04-28 |
| Kaia Health–Symphony Ventures: investment, 202104 financing round Series C totalling $75m incl existing + co-investor Symphony Ventures |
2021-04-28 |
| Kaia Health–UnitedHealth: investment, 202104 financing round Series C totalling $75m incl existing + co-investor Optum Ventures |
2021-04-28 |
| Exciva–Andera Partners: investment, 202104 existent investment of Andera Partners |
2021-04-27 |
| PreComb Therapeutics–High-Tech Gründerfonds: investment, 202104 seed financing round totalling CHF2.2m incl co-lead investor HTGF |
2021-04-26 |
| Anavo Therapeutics–MacDougall Advisors: public relations, 202104 service existent by MacDougall |
2021-04-22 |
| ITM–Petrichor Healthcare: credit, 202104– convertible loan financing totalling €90m led by Petrichor HCM |
2021-04-22 |
| ITM–SEVERAL: credit, 202104– convertible loan financing €90m led by Petrichor HCM with undisclosed other investors |
2021-04-22 |
| Atriva Therapeutics–Germany (govt): grant, 202104– up to €11.4m research funding from BMBF to advance ATR-002 for Covid-19 |
2021-04-21 |
| OxVax–Evotec: investment, 202104 seed financing round totalling €na incl co-lead investor Evotec |
2021-04-21 |
| Sense Biodetection–Earlybird: investment, 202104 financing round Series B totalling $50m incl exisiting + co-investor Earlybird Health |
2021-04-20 |
| Siemens–Biognosys: MS-based biomarker discovery, 202104– strategic agreem marker discovery using HRM-MS for Dx assay development with S Healthineers |
2021-04-13 |
| Mestex–Grünenthal: investment, 202104 acquisition 100% of Mestex AG by Grünenthal |
2021-04-12 |
| Stimit–Dräger: investment, 202104 acquisition of majority share in Stimit AG by Drägerwerk AG & Co KGaA |
2021-04-01 |
| Cytosurge–Univ Tübingen: genome editing, 202103 collab cell line developm using FluidFM nano-injection for single cell CRISPR gene engineering |
2021-03-24 |
| Formycon–Leukocare: biopharmaceuticals, 202103– collab Master Service Agreem developm stable formulations for biosimilars/biologics of Formycon |
2021-03-24 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
